Aerosol drug devices can treat a host of diseases such as lung diseases, pneumonia, diabetes, asthma, etc. which further drives the global aerosol delivery devices market during the forecast years.
Researchmoz elucidates the market in detail including market size, opportunities, restraints, drivers, and segment domination.
Chronic obstructive pulmonary disease (COPD) to Drive the Market
Chronic obstructive pulmonary disease (COPD) is the most common death-causing disease in the world and drug delivery via inhalation process is the common treatment for COPD. The disease affects nearly 15% of the US population, thus, the increasing prevalence of COPD is projected to drive the global aerosol delivery devices market.
The drug delivery system has had a transformational shift since its inception, from just metered-dose inhalers to handheld inhalers such as dry powder and soft mist inhalers. The growing patient population and growing need for targeted therapies have encouraged a better understanding of the applications of aerosol drug delivery.
Read More:https://www.beetribune.com/aerosol-delivery-devices-market-forecast/
